BIOSPECIFICS TECHNOLOGIES CORP.

                               POWER OF ATTORNEY

     Know all by these present, that I, the undersigned director and/or officer
of BioSpecifics Technologies Corp., a Delaware corporation (the "Company"),
hereby constitute and appoint Carl A. Valenstein and any Assistant Secretary of
the Company, and each of them, my true and lawful attorneys-in-fact and agents,
with full power to act, together or each without the other, with full power of
substitution and resubstitution, for me and in my name, place and stead, in any
and all capacities:

   (i)    to execute and file for and on behalf of the undersigned any
          reports on Forms 3, 4 and 5 (including any amendments thereto and any
          successors to such Forms) with respect to ownership acquisition or
          disposition of securities of the Company that the undersigned may be
          required to file with the U.S. Securities and Exchange Commission (the
          "SEC") in accordance with Section 16(a) of the Securities Exchange Act
          of 1934, as amended (the "Exchange Act"), and the rules promulgated
          thereunder;

   (ii)   to execute and file for and on behalf of the undersigned any
          voluntary filings under Section 16(a) of the Exchange Act;

   (iii)  to request electronic filing codes from the SEC by filing the
          Form ID (including amendments thereto) and any other documents
          necessary or appropriate to obtain codes and passwords enabling the
          undersigned to file such reports electronically;

   (iv)   to prepare, file, and submit any documents or reports that may be
          required under SEC Rule 144 to permit the undersigned to sell Company
          common stock without registration under the Securities Act of 1933, as
          amended (the "Securities Act") in reliance on Rule 144 as amended from
          time to time; or

   (v)    take any other action of any type whatsoever in connection with
          the foregoing which, in the opinion of such attorneys-in-fact, may be
          of benefit to, in the best interest of, or legally required by, the
          undersigned, it being understood that the documents executed by such
          attorneys-in-fact on behalf of the undersigned pursuant to this Power
          of Attorney shall be in such form and shall contain such terms and
          conditions as such attorneys-in-fact may approve in such attorney-in-
          fact's or attorneys-in-fact's discretion.

     The undersigned acknowledges that the foregoing attorneys-in-fact, in
serving in such capacity at the request of the undersigned, are not assuming,
nor is the Company assuming, any of the undersigned's responsibilities to comply
with Section 16(a) of the Exchange Act or the Securities Act. The Company will
use all reasonable efforts to apprise the undersigned of applicable filing
requirements for purposes of Section 16(a) of the Exchange Act or the Securities
Act.

     This Power of Attorney shall remain in full force and effect until the
undersigned is no longer required to file Forms 3, 4 and 5 with respect to the
undersigned's holdings and transactions in securities issued by the Company,
unless earlier revoked by the undersigned in a signed writing delivered to the
foregoing attorneys-in-fact. This Power of Attorney revokes and replaces any
prior Power of Attorney executed by the undersigned with respect to the
ownership, acquisition or disposition of securities of the Company.





     IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be
executed as of this 9th day of April, 2020.

                                        /s/ Joseph E. Truitt
                                        -----------------------------------
                                        Joseph E. Truitt